Pelthos Therapeutics Inc. · AMEX:PTHS
Ikarian Capital, LLC reported a 8.40% stake in Pelthos Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ikarian Capital, LLC reported a 8.40% stake in Pelthos Therapeutics Inc., 255,758 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 8.40%
- Shares
- 255,758
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 8.40% | 255,758 |
| Neil Shahrestani | 8.40% | 255,758 |
Source
Related
- Pelthos Therapeutics Inc.
- Ikarian Capital, LLC
- Pelthos Therapeutics Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · May 15, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Nov 14, 2025
- Form 4 · Friedberg Ezra M · Oct 6, 2026
- Form 4 · Greenleaf Peter · Oct 6, 2026
- Form 4 · Pauls Matthew · Oct 6, 2026
- Form 4 · Friedberg Ezra M · Jul 7, 2026
- Form 4 · Pauls Matthew · Jul 7, 2026